The fight for affordable insulin took an exciting turn last week, as new legislation was introduced: ‘S. 3700, The Affordable Insulin Now Act.’

Act now! Ask your U.S. Senators to co-sponsor this critical legislation for insulin affordability.

The Affordable Insulin Now Act is a simplified pathway to pass Breakthrough T1D-supported insulin affordability measures in the U.S. Senate, including a $35 per month insulin co-pay cap for people with Medicare, employer-sponsored coverage, or insurance bought on the ACA marketplace. This bill also requires commercial insurers to exclude insulin from the deductible.

This is an opportunity to make a difference for insulin affordability. While this legislation does not affect those who are uninsured, it is a significant step forward for many people with T1D. Breakthrough T1D will continue to work with Congress, the Biden Administration, and all other stakeholders to ensure that everyone who needs it has access to affordable insulin.

Please, contact your U.S. Senators today so they know how much this bill means to our community. When you’re done—forward this email to family and friends and share it on social media.

Your engagement as grassroots advocates is essential to driving our insulin affordability advocacy forward. Please contact your U.S. Senators today!

Remember, if you or someone you love needs immediate help with insulin costs, visit jdrf.org/costs.